Search Results

Deals

Theseus Pharmaceuticals Confirms Receipt of Unsolicited Expression of Interest from Foresite Capital, LLC and OrbiMed Advisors LLC and Unsolicited Proposal from Concentra Biosciences LLC

Theseus Pharmaceuticals Confirms Receipt of Unsolicited Expression of Interest from Foresite Capital, LLC and OrbiMed Advisors LLC and Unsolicited Proposal from Concentra Biosciences LLC.

November 27, 2023

·

4 min read

Zealand Pharma major shareholder announcement: Avoro Capital Advisors LLC

Zealand Pharma A/S announces the receipt on 9 January 2024 of notification pursuant to Section 38 of the Danish Capital Markets Act from Avoro Capital Advisors LLC.

January 10, 2024

·

1 min read

Biotech Beach

MDxHealth Reports Q1-2024 Results and Announces Growth Capital from OrbiMed

MDxHealth SA announced its financial results for the first quarter ended March 31, 2024 and the closing of a new debt facility with OrbiMed.

May 1, 2024

·

12 min read

Press Releases

Poxel Announces Agreement with OrbiMed to Monetize a portion of TWYMEEG® Royalties for USD 50 million

September 30, 2024

·

15 min read

Press Releases

Acella Pharmaceuticals, LLC, an Alora Pharmaceuticals, LLC Subsidiary, Partners with Paloma Health for Hypothyroidism Patients

October 23, 2024

·

2 min read

Business

Eyam Announces Nicholas Franco Appointment to Board of Advisors

Eyam is pleased to announce the appointment of Nicholas Franco to its Board of Advisors.

June 24, 2024

·

2 min read

Business

ChoiceSpine LLC Announces Changes in Leadership Roles

ChoiceSpine LLC, a medical device company in Knoxville, Tennessee, and privately held by Altus Capital Partners, announces that Marty Altshuler and Rick Henson, founders and Co-Presidents of ChoiceSpine, transitioned to Executive Advisor roles following 18 years of leading the company.

January 18, 2024

·

3 min read

Deals

INTEGRATED ONCOLOGY NETWORK ANNOUNCES THE ACQUISITION OF UROLOGY PARTNERS, LLC

Integrated Oncology Network, LLC (“ION”), a portfolio company of Silver Oak Services Partners, LLC (“Silver Oak”), today announced the acquisition of Urology Partners, LLC.

May 2, 2024

·

3 min read

Spexis announces engagement with Maxim Group LLC as M&A advisor to support evaluation of strategic transactions

Spexis AG, a clinical-stage biopharmaceutical company focused on rare diseases and oncology, announced that it has engaged Maxim Group LLC as a financial advisor to assist in the evaluation of strategic alternatives and fundraising opportunities.

June 30, 2023

·

2 min read

Business

Scilex Holding Company Partners with New National Distributor, Endeavor Distribution LLC.

Scilex Holding Company announced that in anticipation of selling our commercially available products to new and current special customers, Scilex has entered into a non-exclusive distribution agreement with a well-known and highly respected distributor with over 10 years of sales excellence, Endeavor Distribution LLC.

June 20, 2024

·

7 min read